Our recently published results with URMC-099 in a mouse model of experimental autoimmune encephalitis suggest that this compound may be therapeutically advantageous to a more highly selective MLK3 inhibitor [17]. This evidence concerns the gene MAP3K11 and autoimmune encephalitis.